vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Life360, Inc. (LIF). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $146.0M, roughly 1.9× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs -14.3%, a 103.1% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 4.7%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $3.3M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
EHAB vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $146.0M |
| Net Profit | $-38.7M | $129.7M |
| Gross Margin | — | 75.1% |
| Operating Margin | -12.3% | 6.1% |
| Net Margin | -14.3% | 88.8% |
| Revenue YoY | 4.7% | 26.4% |
| Net Profit YoY | 15.9% | 1425.9% |
| EPS (diluted) | $-0.76 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $146.0M | ||
| Q3 25 | $263.6M | $124.5M | ||
| Q2 25 | $266.1M | $115.4M | ||
| Q1 25 | $259.9M | $103.6M | ||
| Q4 24 | $258.2M | $115.5M | ||
| Q3 24 | $253.6M | $92.9M | ||
| Q2 24 | $260.6M | $84.9M | ||
| Q1 24 | $262.4M | $78.2M |
| Q4 25 | $-38.7M | $129.7M | ||
| Q3 25 | $11.1M | $9.8M | ||
| Q2 25 | $5.2M | $7.0M | ||
| Q1 25 | $17.8M | $4.4M | ||
| Q4 24 | $-46.0M | $8.5M | ||
| Q3 24 | $-110.2M | $7.7M | ||
| Q2 24 | $-200.0K | $-11.0M | ||
| Q1 24 | $200.0K | $-9.8M |
| Q4 25 | — | 75.1% | ||
| Q3 25 | — | 78.0% | ||
| Q2 25 | — | 78.4% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 75.0% | ||
| Q1 24 | — | 76.7% |
| Q4 25 | -12.3% | 6.1% | ||
| Q3 25 | 6.4% | 4.6% | ||
| Q2 25 | 6.3% | 1.7% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | -16.0% | 4.9% | ||
| Q3 24 | -38.6% | -5.3% | ||
| Q2 24 | 4.3% | -2.8% | ||
| Q1 24 | 4.9% | -8.2% |
| Q4 25 | -14.3% | 88.8% | ||
| Q3 25 | 4.2% | 7.9% | ||
| Q2 25 | 2.0% | 6.1% | ||
| Q1 25 | 6.8% | 4.2% | ||
| Q4 24 | -17.8% | 7.4% | ||
| Q3 24 | -43.5% | 8.3% | ||
| Q2 24 | -0.1% | -12.9% | ||
| Q1 24 | 0.1% | -12.5% |
| Q4 25 | $-0.76 | $1.53 | ||
| Q3 25 | $0.22 | $0.11 | ||
| Q2 25 | $0.10 | $0.08 | ||
| Q1 25 | $0.35 | $0.05 | ||
| Q4 24 | $-0.92 | $0.14 | ||
| Q3 24 | $-2.20 | $0.09 | ||
| Q2 24 | $0.00 | $-0.15 | ||
| Q1 24 | $0.01 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $494.3M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $548.2M |
| Total Assets | $1.2B | $959.7M |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $494.3M | ||
| Q3 25 | $56.9M | $455.7M | ||
| Q2 25 | $37.1M | $432.7M | ||
| Q1 25 | $39.5M | $168.9M | ||
| Q4 24 | $28.4M | $159.2M | ||
| Q3 24 | $45.7M | $159.0M | ||
| Q2 24 | $28.5M | $160.8M | ||
| Q1 24 | $36.5M | $73.4M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | $5.2M |
| Q4 25 | $534.0M | $548.2M | ||
| Q3 25 | $566.8M | $391.4M | ||
| Q2 25 | $552.4M | $366.7M | ||
| Q1 25 | $543.2M | $376.3M | ||
| Q4 24 | $523.5M | $358.5M | ||
| Q3 24 | $566.1M | $339.7M | ||
| Q2 24 | $674.3M | $326.7M | ||
| Q1 24 | $672.3M | $239.8M |
| Q4 25 | $1.2B | $959.7M | ||
| Q3 25 | $1.2B | $787.5M | ||
| Q2 25 | $1.2B | $753.6M | ||
| Q1 25 | $1.2B | $455.4M | ||
| Q4 24 | $1.2B | $441.6M | ||
| Q3 24 | $1.3B | $427.4M | ||
| Q2 24 | $1.4B | $405.9M | ||
| Q1 24 | $1.4B | $318.8M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $36.8M |
| Free Cash FlowOCF − Capex | $3.3M | $36.6M |
| FCF MarginFCF / Revenue | 1.2% | 25.1% |
| Capex IntensityCapex / Revenue | 0.4% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $36.8M | ||
| Q3 25 | $37.8M | $26.4M | ||
| Q2 25 | $10.6M | $13.3M | ||
| Q1 25 | $17.9M | $12.1M | ||
| Q4 24 | $-4.1M | $12.3M | ||
| Q3 24 | $28.4M | $6.3M | ||
| Q2 24 | $9.6M | $3.3M | ||
| Q1 24 | $17.3M | $10.7M |
| Q4 25 | $3.3M | $36.6M | ||
| Q3 25 | $36.2M | $25.6M | ||
| Q2 25 | $8.7M | $12.7M | ||
| Q1 25 | $17.6M | $11.9M | ||
| Q4 24 | $-4.7M | $11.2M | ||
| Q3 24 | $27.7M | $6.3M | ||
| Q2 24 | $8.9M | $3.2M | ||
| Q1 24 | $15.5M | — |
| Q4 25 | 1.2% | 25.1% | ||
| Q3 25 | 13.7% | 20.6% | ||
| Q2 25 | 3.3% | 11.0% | ||
| Q1 25 | 6.8% | 11.5% | ||
| Q4 24 | -1.8% | 9.7% | ||
| Q3 24 | 10.9% | 6.8% | ||
| Q2 24 | 3.4% | 3.8% | ||
| Q1 24 | 5.9% | — |
| Q4 25 | 0.4% | 0.2% | ||
| Q3 25 | 0.6% | 0.6% | ||
| Q2 25 | 0.7% | 0.6% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.2% | 1.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | — | 0.28× | ||
| Q3 25 | 3.41× | 2.70× | ||
| Q2 25 | 2.04× | 1.90× | ||
| Q1 25 | 1.01× | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
LIF
Segment breakdown not available.
